Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV

  • STATUS
    Recruiting
  • participants needed
    244
Send
Updated on 19 February 2024

Summary

The research study is being conducted to examine the effects of personalized smoking cessation medication treatment in order to help people with HIV/AIDS to quit smoking. During the study, participants will take either varenicline (brand name Chantix®) or use the nicotine patch, and they will receive smoking cessation therapy with either standard smoking cessation medication adherence advice or Managed Problem Solving intervention (MAPS).
 
If you agree to join the study, you will be asked to complete the following research procedures:
·         Attend 3 in person sessions (including this one) and complete 5 phone sessions.
·         Take the study medication (either varenicline or nicotine patch) for up to 12 weeks.
·         Complete up to 5 smoking cessation therapy sessions.
·         Provide biological samples and physiological assessments.
·         Complete brief psychiatric assessments and a routine medical history.
 
Your individual participation will last for about 7 months. By participating in this research study, you will have the opportunity to participate in a smoking cessation program, which includes counseling and varenicline and/or nicotine patch, at no cost.

If you are interested please click the following link to see if you are eligible:

PENN HTO Recruitment Survey

Description


FAQ


Details
Condition Smoking,HIV
Age 18years - 99years
Clinical Study IdentifierNCT04176172
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.